Amkay Products debuts with 90% premium on BSE SME platform

Ahead of the , the company's shares traded with a premium of Rs 55 in the unlisted .

The , which was completely a fresh equity issue of 22.9 lakh shares, received massive response from investors with an overall subscription of over 700 times at close.

The net proceeds from the public offer will be used for funding capital expenditure, working capital requirements and other general corporate purposes.

The company , assembles and markets a comprehensive portfolio of , disposables and other healthcare products like face masks, alcohol swabs, lancet needles, nebulizers, pulse oximeters, surgeon caps etc.

Also Read:

In addition, it is also engaged in branding and marketing of some of the products like diapers, plastic gloves, suction machines among others.

started its operations in 2008 with manufacturing and supply of one product in a manufacturing unit taken on rent at Vasai in Mumbai. Over the years, more products were added to its portfolio and for further expansion, the company shifted to bigger manufacturing units.

The company’s boasts of over 30 products in its portfolio including respiratory disease related medical devices, surgical disposables and home healthcare.

The medical devices sector in India comprises large multinationals, small and midsized companies. The size of the Indian medical devices market is estimated at Rs 90,000 crore ($11 billion) in 2022 and is expected to grow to $50 billion by 2030 with a CAGR of 16.4%.

For the period ended December 2023, the company clocked of Rs 22.73 crore and net profit of Rs 2.15 crore.

acted as the lead manager to the issue and was the registrar.